Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer
Study Information
Alliance Study ID: ACOSOG-Z4033
NCT Study ID (ClinicalTrials.gov): NCT00109876
Alliance Committee: Respiratory Cancer
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Damian E. Dupuy, MD
Status: COMPLETED
Study Description
This pilot clinical trial studies how well radiofrequency ablation works in treating patients with stage IA non-small cell lung cancer. Radiofrequency ablation uses high-frequency electric current to kill tumor cells. Computed tomography (CT)-guided radiofrequency ablation may be a better treatment for non-small cell lung cancer.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information